Related Experiment Video
Updated: Nov 7, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
The role of the extracellular matrix protein TGFBI in cancer
Armando Corona1, Gerard C Blobe2
1Department of Pharmacology and Cancer Biology, Duke University Medical center, USA.
Abstract:
The secreted extracellular protein, transforming growth factor beta induced (TGFBI or βIGH3), has roles in regulating numerous biological functions, including cell adhesion and bone formation, both during embryonic development and during the pathogenesis of human disease. TGFBI has been most studied in the context of hereditary corneal dystrophies, where mutations in TGFBI result in accumulation of TGFBI in the cornea. In cancer, early studies focused on TGFBI as a tumor suppressor, in part by promoting chemotherapy sensitivity. However, in established tumors, TGFBI largely has a role in promoting tumor progression, with elevated levels correlating to poorer clinical outcomes. As an important regulator of cancer progression, TGFBI expression and function is tightly regulated by numerous mechanisms including epigenetic silencing through promoter methylation and microRNAs. Mechanisms to target TGFBI have potential clinical utility in treating advanced cancers, while assessing TGFBI levels could be a biomarker for chemotherapy resistance and tumor progression.
Insights
Transforming growth factor beta induced (TGFBI) protein impacts cell adhesion and bone formation. While initially viewed as a tumor suppressor, TGFBI promotes advanced cancer progression and chemotherapy resistance.
Area of Science:
- Molecular Biology
- Cancer Biology
- Biochemistry
Background:
- Transforming growth factor beta induced (TGFBI) is an extracellular protein involved in cell adhesion and bone formation.
- Mutations in TGFBI cause hereditary corneal dystrophies due to protein accumulation.
- TGFBI's role in cancer has shifted from tumor suppressor to promoter of tumor progression in established cancers.
Purpose of the Study:
- To explore the dual role of TGFBI in biological functions and human diseases.
- To investigate the regulatory mechanisms of TGFBI expression and function.
- To assess the potential of TGFBI as a therapeutic target and biomarker in cancer.
Main Methods:
- Analysis of existing literature on TGFBI's biological roles and disease associations.
- Review of studies on TGFBI's function in cancer, including its tumor suppressor and promoter activities.
- Examination of epigenetic and microRNA-mediated regulation of TGFBI.
Main Results:
- TGFBI is implicated in embryonic development, bone formation, and corneal diseases.
- In cancer, TGFBI acts as a tumor suppressor early on but promotes progression in advanced tumors.
- Elevated TGFBI levels correlate with poorer clinical outcomes and chemotherapy resistance.
Conclusions:
- TGFBI plays a complex, context-dependent role in human health and disease.
- Targeting TGFBI offers potential clinical utility for advanced cancers.
- TGFBI levels can serve as a biomarker for chemotherapy resistance and tumor progression.
Related Concept Videos
TGF - β Signaling Pathway
The Tumor Microenvironment
The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
The Extracellular Matrix
Extracellular Matrix
Intracellular Signaling Affects Focal Adhesions
Some...

